by Revolver

The problem here is that a reduced population does not necessarily entail a reduction in manufacturing and industry. Major polluting countries like China and India give no indication of scaling down carbon-emitting coal plants. Moreover, Green technology—the wind farm/solar array nexus—is notoriously expensive, unreliable, landscape defiling, and fossil-fuel dependent with its inevitable and frequent outages. Similar drawbacks are true of the half-ton, non-disposable, toxic EV lithium batteries now all the rage in the plans of quantitative futurists. The Green solution is a neon green figment, largely unworkable in the long run. Energy extraction remains essential. Fracking and nuclear are the most feasible alternatives but are ruled out by ecological enthusiasts.

Another discrepancy in Gates’ argument involves his claim that population can be reduced by making people healthier. In defending Gates, Maarten Schenk at Lead Stories points to arguments that wealthier and healthier people produce fewer children since they don’t have to adjust for massive child mortality. “So, what about the remarks about ‘new vaccines, health care, reproductive health services’?” Schenk asks rhetorically, and answers:

That is just what specialists studying population growth are saying. As people get richer, they get more access to better healthcare so they stop having lots of babies because the risk of their children dying at an early age takes a steep dive. This means the total population stabilizes and stops growing after a while.

On the surface, this looks like a strong argument, especially with respect to underdeveloped countries. The problem is that advantaged people may enjoy having more children—perhaps not in the decadent West at this time in history, but possibly in the future, and certainly as we see now in countries like Hungary and Poland, which are returning to their ancestral traditions, restoring the sanctity of marriage, re-establishing the vitality of the Christian faith and financially incentivizing procreation. The result is rapidly growing families. In such countries, healthy people produce more, not fewer, children. The formula could be: H=V=C. Health equals Vitality equals Children. Gates’ X may conceivably turn out to be non-X.

By Karen Kingston (from an interview with Brannon House-Lindell Tv.com)

Brannon House interviewed Karen Kingston, a former Pfizer employee, who revealed that Moderna's formulation contains the HELA cell line which is derived from a 1953 cervical cancer cell line. Why would anyone do this type of thing unless the true purpose was to reduce the population? Luceriferase modified RnA + vaccine is an experimental delivery system means for trans humanism operations which potentially preps your body for future biological enhancements WHAT is LUCERIFERASE? No accident this name was chosen.

https://cairnsnews.org/2021/08/27/lying-fact-checkers-caught-out-on-not-so-secret-pfizer-moderna-contaminant/

A FORMER Pfizer employee has confirmed the scandal revealed on Stew Peters’ online TV show that mRNA vaccines are contaminated with nano-particles of the poisonous-to-humans metal Graphene oxide, as stated by Dr Jane Ruby on the show early in July. The so-called International Fact Checking Network, funded by mainstream media and globalist foundations, went into overdrive after Dr Ruby’s claims on Peters’ show back in July. Kingston then came on to back up what Dr Ruby claimed, but as a Pfizer insider and whistle blower she was able to more intimately detail the processes involved in the development of the vaccine. These are bio-weapons!

Stew Peters With Karen Kingston – Former Pfizer Employee Confirms Poison in COVID ‘Kill Shot’

Kingston revealed Cardiac conditions such as myocarditus and elimination of your platelets and other issues such as encephalitis, Covid 19 adverse reactions known as Covid breakthroughs, encompasses many unreported vaccines complications to the American public.

Bill & Melinda Gates, who has a EUGENICS background (population control) heavily involved in vaccine to the Americans with a particular interest in gene extinction technology.

"What's in the vaccines has been proven to accelerate the formation of cancer cells and if you have cancer it's going to accelerate the cancer growth in your body in a couple of different ways," Kingston said. Note the strong appearance of the HELA cell Line in the Chart.  "One is the patent contains the HeLa stem cell line, an immortal stem cell line from a woman from the 1950s who died from cervical cancer. Unlike the normal stem cells, this is from the most aggressive cancer.

"It accelerates cancerous cell growth. It's very deadly."

How to get Americans to comply and kill themselves by buying into the vaccine lies. They used behavioral insights in partnership with the Organization for Economic Cooperation and Development [OECD], including Harvard Business at the helm of it, to know how to psychologically, mentally and emotionally manipulate Americans to do something that had no benefit to them, and then to cover it up."

by Alice Dreger and Ellen K. Feder

[A 2014 article that details the questionable practices of modern medicine which both involves fraud and an overt application of eugenics rather than health care.  It is offered as a public service information source along with the caveat to beware of scientific studies which are usually wrong. . [Emphasis - DNI] - ED]

Newly available documents show conflicts of interest for the FDA ethicist who investigated a fetal drug experiment.  

Pediatric endocrinologist Maria New, now at Mount Sinai School of Medicine in New York, is an internationally-recognized specialist in congenital adrenal hyperplasia, a genetic condition that can cause female fetuses to develop intersex (in-between male and female) genitals. For over a decade, Dr. New has encouraged pregnant women at risk of having a child with congenital adrenal hyperplasia to take the steroid dexamethasone starting as early as 3 weeks of pregnancy to try to prevent intersex development.

Dr. New has consistently described this extremely controversial off-label (i.e., not government-approved) use as safe and effective. In truth, there has never been a placebo-controlled trial of this use, and the only long-term prospective trial ever conducted resulted in so many “severe” adverse events that, in 2010, that study’s research team (a Swedish group) went to their ethics board to say they were halting the use altogether.

Dr. New’s aggressive “safe and effective” promotion of this fetal intervention—an intervention designed to cross the placenta and change fetal development—would be shocking enough. But we were shaken in late 2009 when we discovered that, even while she was direct-to-consumer advertising the intervention as having been “found safe for mother and child,” she was taking NIH grant money to study retrospectively whether it was safe and effective.

 In February of 2010, we along with thirty colleagues in bioethics and allied fields sent letters of concern to the U.S. Food and Drug Administration (FDA) and Office for Human Research Protections (OHRP) asking them to investigate the actions of Dr. New. At the FDA, the investigation was assigned to Robert “Skip” Nelson, a pediatric ethicist. Documents obtained through a Freedom of Information request suggest that Nelson proposed to OHRP that he handle the main part of the prenatal dexamethasone investigation for that agency as well. Ultimately the OHRP findings relied largely on a memo provided to them by Nelson as an FDA official.

While the federal investigation was ongoing, in May of 2010 the American Journal of Bioethics (AJOB) circulated a manuscript (in advance of publication, inviting open peer commentaries) attacking our letters of concern, saying they represented an instance of “unethical transgressive bioethics.”

At the time, we were not aware of conflicts of interest in the federal investigation or the AJOB article, because none were disclosed. Here is what we now know, including from material obtained just this week through the Freedom of Information Act:

First, neither the original AJOB manuscript (May 2010) nor the final published article (September 2010) included a conflict of interest statement from the authors. The lead author, Larry McCullough, failed to disclose that he held paid positions with the two medical schools implicated in the investigation (Mount Sinai and Cornell). The second author, Frank Chervenak, failed specifically to disclose that he was (and still is) Chair of Obstetrics and head of the Maternal-Fetal Medicine unit at the medical school where New “treated” over 600 pregnancies with prenatal dex.  Chervenak also failed to disclose that he served as “key personnel” on New’s NIH grant.

Responses to our Freedom of Information requests show that Larry McCullough gave the AJOB original manuscript to the federal investigators at OHRP prior to publication, in an attempt to undermine the claims in our complaints. No conflict of interest disclosures were attached to the manuscript. This suggests that OHRP personnel would have seen the McCullough and Chervenak criticisms of our request for an investigation, but would not have known of the authors’ conflicts of interest.

Second, it appears that Nelson did not disclose to his FDA or OHRP colleagues that he was a member of the editorial board of AJOB – the journal in which the criticisms were published. One might feel less concerned about this particular undisclosed conflict were it not for the fact that, like the AJOB target article, Nelson’s official FDA findings on prenatal dex misrepresented key facts, including whether the FDA had previously reviewed New’s use of this steroid on first-trimester fetuses.

Third, this week we have obtained additional material through our Freedom of Information request showing that Nelson was, in fact, developing an even deeper relationship with AJOB while he was conducting the prenatal dex investigation. At the very time Nelson was investigating our complaints, he was also negotiating to become editor-in-chief of a new AJOB journal, AJOB Primary Research (since renamed AJOB Empirical Bioethics).

A May 2010 email conversation between Nelson and others at the FDA shows that Nelson was to be compensated by AJOB not only with the editor-in-chief title, but also with $10,000 per year, for editorial assistance. In the email conversation about the new position with AJOB, Nelson never disclosed that the journal was being used to aggressively (dare we say “transgressively”?) undermine complaints he was investigating.

Curiously, Nelson’s FDA memo and the associated OHRP findings on prenatal dex were released on virtually the same day in September 2010 that AJOB published the McCullough and Chervenak “target article” and responses to it. The timing of this “coincidence” was openly celebrated by Glenn McGee, then editor-in-chief of AJOB: “With the release of the September issue of the Journal, both the FDA and OHRP have released letters responding to the complaints that are the subject of the Target Article…”

What might once have been thought fortuitous timing must now be examined through the lens of conflicts of interest, as we now know that, by September 2010, Nelson was working in titled and compensated positions for both the FDA and AJOB.

Fourth, in December 2010, AJOB published a “vindication” by Dr. New that consisted mostly of a long quote from Nelson’s FDA response to our letter. Consistent with the established pattern of non-disclosure, nowhere in conjunction with New’s “vindication” does one find disclosure of Nelson’s dual role as FDA investigator and key member of the AJOB editorial team.

We have repeatedly appealed to the editorial board of AJOB to add disclosures to all the dex-related publications. That has gotten us nowhere, except to force disclosure of who is on the AJOB conflict-of-interest committee. The committee includes Larry McCullough, specifically representing AJOB Empirical Bioethics, the journal given to Skip Nelson.

---

Larry McCullough, one of the founders of “bioethics”, pop control, research using children, pro-human embryonic stem cell research, etc.:  https://www.google.com/#q=%22Larry+McCullough%22+%22bioethics%22

Frank Chervenak, M.D., ObGyn specialist in maternal and fetal medicine, pro-abortion and woman’s rights, anti-personhood for the unborn, pro-euthanasia, etc.: https://www.google.com/#q=%22Frank+Chervenak%22+%22bioethics%22+%22controversy%22

Glenn McGee, partner with bioethics founder Art Caplan, pro-“designer babies” and human cloning, implicated in conflict of interest in the Celltex corruption case, etc.:  https://www.google.com/#q=%22Glenn+McGee%22+%22bioethics%22

Skip Nelson, Senior Pediatric Ethicist at FDA, promotes research using children, etc.:  https://www.google.com/#q=%22Skip+Nelson%22+%22bioethics%22&start=10

See also “Charges of editorial misconduct at American Journal of Bioethics (AJOB), at: 

http://www.healthnewsreview.org/2011/06/charges-of-editorial-misconduct-at-american-journal-of-bioethics/.

For an extensive analysis and critique of “bioethics”, with extensive references, see my article, "What is 'bioethics'?" (June 3, 2000), UFL Proceedings of the Conference 2000, in Joseph W. Koterski (ed.), Life and Learning X:  Proceedings of the Tenth University Faculty For Life Conference (Washington, D.C.:  University Faculty For Life, 2002), pp. 1-84, at:

http://www.lifeissues.net/writers/irv/irv_36whatisbioethics01.html.  As a First Generationer in this “bioethics”, I hold one of the few Ph.D. concentrations in bioethics the field from the KIE and Dept. of Philosophy, Georgetown University (1991).

--  DNI]